<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05082818</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-10-16</org_study_id>
    <nct_id>NCT05082818</nct_id>
  </id_info>
  <brief_title>Outcome of Treating Bladder Cancer in Sohag University Hospital</brief_title>
  <official_title>Outcome of Treating Urinary Bladder Cancer in Sohag University Hospital Between 2016 to 2020</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective study of outcome of urinary bladder cancer treated in Sohag University hospital&#xD;
      in the past 5 years from 2016 to 2020&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study asses the risk factors, prognosis,disease free survival and overall survive rate&#xD;
      of treating urinary badder cancer&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 30, 2021</start_date>
  <completion_date type="Anticipated">May 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Disease free survival</measure>
    <time_frame>2 weeks after treatment to the time of relapse</time_frame>
    <description>Time from the end of treatment to the date of first relapse</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Bladder Cancer</condition>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Chemotherapy, Radiotherapy and surgery</intervention_name>
    <description>Trans urethral resection of the tumour or radical cystectomy</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Bladder cancer patients of both sex and aged from 18 to 80 years old&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all stages and grades of urinary bladder cancer Any histological types of urinary&#xD;
             bladder cancer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  presence of other malignancies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Samah Refaat</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sohag University hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samah Refaat</last_name>
    <phone>01015484627</phone>
    <email>Samah011102@med.sohag.edu.eg</email>
  </overall_contact>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 15, 2021</study_first_submitted>
  <study_first_submitted_qc>October 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2021</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Samah Refat Ahmed</investigator_full_name>
    <investigator_title>resident of clinical oncology faculty of medicine Sohag University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

